» Articles » PMID: 23812305

Intestinal Iron Homeostasis and Colon Tumorigenesis

Overview
Journal Nutrients
Date 2013 Jul 2
PMID 23812305
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is the third most common cause of cancer-related deaths in industrialized countries. Understanding the mechanisms of growth and progression of CRC is essential to improve treatment. Iron is an essential nutrient for cell growth. Iron overload caused by hereditary mutations or excess dietary iron uptake has been identified as a risk factor for CRC. Intestinal iron is tightly controlled by iron transporters that are responsible for iron uptake, distribution, and export. Dysregulation of intestinal iron transporters are observed in CRC and lead to iron accumulation in tumors. Intratumoral iron results in oxidative stress, lipid peroxidation, protein modification and DNA damage with consequent promotion of oncogene activation. In addition, excess iron in intestinal tumors may lead to increase in tumor-elicited inflammation and tumor growth. Limiting intratumoral iron through specifically chelating excess intestinal iron or modulating activities of iron transporter may be an attractive therapeutic target for CRC.

Citing Articles

An overview of the current evidences on the role of iron in colorectal cancer: a review.

Yousefi M, Masoudi A, Saberi Rounkian M, Mansouri M, Hojat B, Kaveh Samani M Front Oncol. 2025; 15:1499094.

PMID: 40066098 PMC: 11891053. DOI: 10.3389/fonc.2025.1499094.


Effect of Cu- and Fe- Isolated from Environmental Particulate Matter on Mitochondrial Dynamics in Human Colon CaCo-2 Cells.

Cervellati F, Benedusi M, Casoni A, Trinchera G, Vallese A, Ferrara F Biol Trace Elem Res. 2024; .

PMID: 39738852 DOI: 10.1007/s12011-024-04497-7.


Hemoglobin levels in red blood cells and risk of colorectal cancer: A causal investigation based on Mendelian randomization.

Shen J, Qin X, Zeng X, Xiao H, Lai S Medicine (Baltimore). 2024; 103(48):e40562.

PMID: 39612383 PMC: 11608680. DOI: 10.1097/MD.0000000000040562.


Ferroptosis: the balance between death and survival in colorectal cancer.

Fan S, Zhou L, Zhang W, Wang D, Tang D Int J Biol Sci. 2024; 20(10):3773-3783.

PMID: 39113707 PMC: 11302868. DOI: 10.7150/ijbs.96828.


Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers.

Shanmugam R, Majee P, Shi W, Ozturk M, Vaiyapuri T, Idzham K Cancer Discov. 2024; 14(10):1940-1963.

PMID: 38885349 PMC: 11450372. DOI: 10.1158/2159-8290.CD-23-1379.


References
1.
Glei M, Latunde-Dada G, Klinder A, Becker T, Hermann U, Voigt K . Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat Res. 2002; 519(1-2):151-61. DOI: 10.1016/s1383-5718(02)00135-3. View

2.
Liang S, Richardson D . The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1. Carcinogenesis. 2003; 24(10):1601-14. DOI: 10.1093/carcin/bgg116. View

3.
Zimmermann M, Chassard C, Rohner F, NGoran E, Nindjin C, Dostal A . The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr. 2010; 92(6):1406-15. DOI: 10.3945/ajcn.110.004564. View

4.
Dostal A, Chassard C, Hilty F, Zimmermann M, Jaeggi T, Rossi S . Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr. 2011; 142(2):271-7. PMC: 3260059. DOI: 10.3945/jn.111.148643. View

5.
Osborne N, Gurrin L, Allen K, Constantine C, Delatycki M, McLaren C . HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology. 2010; 51(4):1311-8. PMC: 3815603. DOI: 10.1002/hep.23448. View